title: Drug reaction with eosinophilia and systemic symptoms associated with H1N1 vaccination.
authors.forename: N
authors.initials: N
authors.lastname: Hewitt
authors.forename: M
authors.initials: M
authors.lastname: Levinson
authors.forename: G
authors.initials: G
authors.lastname: Stephenson
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology; D004802:Eosinophilia / Q000139:chemically induced* / Q000276:immunology; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000276:immunology; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000517:prevention & control; D008199:Lymphadenitis / Q000276:immunology; D012460:Sulfasalazine / Q000009:adverse effects*; D013577:Syndrome; D014761:Viral Hepatitis Vaccines; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents; D014761:Viral Hepatitis Vaccines; D012460:Sulfasalazine